IFSO Position Statement on the Role of Esophago-Gastro-Duodenal Endoscopy Prior to and after Bariatric and Metabolic Sur
- PDF / 569,473 Bytes
- 19 Pages / 595.276 x 790.866 pts Page_size
- 73 Downloads / 309 Views
REVIEW
IFSO Position Statement on the Role of Esophago-Gastro-Duodenal Endoscopy Prior to and after Bariatric and Metabolic Surgery Procedures Wendy A. Brown 1 & Yazmin Johari Halim Shah 1 & George Balalis 1 & Ahmad Bashir 1 & Almino Ramos 1 & Lilian Kow 1 & Miguel Herrera 1 & Scott Shikora 1 & Guilherme M. Campos 1 & Jacques Himpens 1 & Kelvin Higa 1
# Springer Science+Business Media, LLC, part of Springer Nature 2020
Abstract One of the roles of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) is to provide guidance on the management of patients seeking surgery for adiposity-based chronic diseases. The role of endoscopy around the time of endoscopy is an area of clinical controversy. In 2018, IFSO commissioned a task force to determine the role of endoscopy before and after surgery for the management of adiposity and adiposity-based chronic diseases. The following position statement is issued by the IFSO Endoscopy in Bariatric/Metabolic Surgery Taskforce. It has been approved by the IFSO Scientific Committee and Executive Board. This statement is based on current clinical knowledge, expert opinion, and published peer-reviewed scientific evidence. It will be reviewed regularly. Keywords Esophago-Gastro-Duodenal Endoscopy . Bariatric Surgery . IFSO Position Statement . Systematic Review
Preamble The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) has played an integral role in educating both the metabolic surgical and the medical community about the best management of patients who have undergone surgery for adiposity-based chronic diseases. The role of endoscopy around the time of bariatric surgery is currently an area of clinical controversy. In 2018, IFSO commissioned a task force (Appendix 1) to determine if routine endoscopy should be undertaken prior to and after surgery for the management of adiposity and adiposity-based chronic diseases. The following position statement is issued by the IFSO Endoscopy in Bariatric/Metabolic Surgery Taskforce and has been approved by the IFSO Scientific Committee and The IFSO appointed task force reviewing the literature on Endoscopy in Bariatric Surgery * Wendy A. Brown [email protected] 1
International Federation for the Surgery of Obesity and Metabolic Disorders, Rione Sirignano, 5, 80121 Naples, Italy
Executive Board. This statement is based on current clinical knowledge, expert opinion, and published peer-reviewed scientific evidence. It will be reviewed on a regular basis.
Background Surgery is considered to be the most effective and durable treatment for adiposity-based chronic diseases for individuals with more severe classifications of obesity. These procedures not only provide substantial weight loss but also improve health, well-being and increase longevity [1–8]. The number of bariatric/metabolic procedures being performed world-wide is increasing each year. According to the latest IFSO survey, there were 191,326 Roux-en-Y gastric bypass (RYGB); 340,550 longitudinal sleeve gastrecto
Data Loading...
